Thompson's PRs continue to be vague and fail to address the month-by-month status of production. I didn't buy any shares on this news. Did you?
So many investors have a long experience with KBLB failing to follow up on significant developments. Remember the immunity silkworms? We never learned what happened when they were tested. Nearly pure spider silk? Has that been replaced by Darwin's Bark silk? Using silkworms to produce valuable drugs (like insulin) in place of sericin? No clue about where that is.
I'd love to see a quarter for my shares. 50 cents would be amazing. A dollar a share lands me at the liquor store buying up all their champagne. Multi-dollar share prices mean I'm flipping through car magazines, deciding how many Ferraris and how many Lamborghinis I want to buy, and trying to find a house with a 5+ car garage.
We need solid information on production, distribution, and sales to start breaking down some of those barriers, not vague news about a new strain.
Market Data 
Markets 
AI
